Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €79.12 | €87.48 | 10.560% |
| Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €2.16 | €12.09 | 459.694% |
| Eli Lilly Corp. | 51 | 0 | 7 | 0 | €727.60 | €766.92 | 5.404% |
| Enanta Pharmaceuticals Inc. | 5 | 4 | 0 | 1 | €12.70 | €26.92 | 111.996% |
| Enlivex Therapeutics Ltd. | 1 | 0 | 1 | 0 | €1.54 | - | - |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.99 | €8.39 | 322.053% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €201.10 | €204.50 | 1.691% |
| Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
| Exelixis Inc. | 17 | 0 | 2 | 0 | €20.26 | €25.64 | 26.531% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €16.56 | €28.17 | 70.095% |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.48 | €6.00 | 72.662% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.91 | €8.27 | 111.304% |
| Fresenius Medical Care AG & Co KGaA ADR | 3 | 1 | 1 | 0 | €19.10 | €21.00 | 9.948% |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €40.43 | €48.50 | 19.960% |
| Fresenius SE & Co. KGaA | 4 | 0 | 2 | 0 | €28.14 | - | - |
| G1 Therapeutics | 14 | 1 | 2 | 0 | €3.53 | €10.56 | 199.291% |
| Galmed Pharmaceuticals Ltd. | 4 | 0 | 0 | 0 | €0.34 | €61.56 | 17795.087% |
| Geron Corp. | 11 | 0 | 3 | 0 | €3.70 | €4.60 | 24.203% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €103.10 | €110.00 | 6.693% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.57 | €86.77 | 40.931% |
| Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.53 | €7.35 | 379.869% |
| GSK plc | 1 | 0 | 0 | 0 | €20.00 | - | - |
| GSK plc ADR | 4 | 0 | 0 | 0 | €39.80 | €35.00 | -12.060% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €85.50 | €97.90 | 14.505% |